These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190 [TBL] [Abstract][Full Text] [Related]
4. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845 [TBL] [Abstract][Full Text] [Related]
5. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
6. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [TBL] [Abstract][Full Text] [Related]
7. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241 [TBL] [Abstract][Full Text] [Related]
8. 18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine. Kirchner J; Sawicki LM; Deuschl C; Grüneisen J; Beiderwellen K; Lauenstein TC; Herrmann K; Forsting M; Heusch P; Umutlu L PLoS One; 2017; 12(7):e0180349. PubMed ID: 28683109 [TBL] [Abstract][Full Text] [Related]
9. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565 [TBL] [Abstract][Full Text] [Related]
11. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Fong Y; Saldinger PF; Akhurst T; Macapinlac H; Yeung H; Finn RD; Cohen A; Kemeny N; Blumgart LH; Larson SM Am J Surg; 1999 Oct; 178(4):282-7. PubMed ID: 10587184 [TBL] [Abstract][Full Text] [Related]
12. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072 [TBL] [Abstract][Full Text] [Related]
13. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351 [TBL] [Abstract][Full Text] [Related]
14. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615 [TBL] [Abstract][Full Text] [Related]
16. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851 [TBL] [Abstract][Full Text] [Related]
17. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208 [TBL] [Abstract][Full Text] [Related]
18. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075 [TBL] [Abstract][Full Text] [Related]
19. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Ramos E; Valls C; Martinez L; Lladó L; Torras J; Ruiz S; Gamez C; Serrano T; Fabregat J; Rafecas A Ann Surg Oncol; 2011 Sep; 18(9):2654-61. PubMed ID: 21431987 [TBL] [Abstract][Full Text] [Related]
20. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]